Skip to main content

eXp World Holdings Reports Q3 2025 Results

eXp World Holdings Reports Q3 2025 ResultseXp World Holdings Reports Q3 2025 ResultsBELLINGHAM, Wash., Nov. 06, 2025 (GLOBE NEWSWIRE) — eXp World Holdings, Inc. (Nasdaq: EXPI), or the “Company”, the holding company for eXp Realty®, FrameVR.io and SUCCESS® Enterprises, today announced financial results for the third quarter ended September 30, 2025. “Our third quarter results underscore the strength of eXp’s model and the power of our agents,” said Leo Pareja, CEO of eXp Realty. “Continued momentum in agent growth, productivity and retention are driving higher revenue, profitability and overall performance. Our agent-first culture, combined with ongoing innovation across the eXp platform, continues to attract and empower top agents and teams around the world. As we scale, our focus remains on delivering even greater value...

Continue reading

Palomar Holdings, Inc. Reports Third Quarter 2025 Results

LA JOLLA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or “Company”) reported net income of $51.5 million, or $1.87 per diluted share, for the third quarter of 2025 compared to net income of $30.5 million, or $1.15 per diluted share, for the third quarter of 2024. Adjusted net income(1) was $55.2 million, or $2.01 per diluted share, for the third quarter of 2025 as compared to $32.4 million, or $1.23 per diluted share, for the third quarter of 2024. Third Quarter 2025 HighlightsGross written premiums increased by 43.9% to $597.2 million compared to $415.0 million in the third quarter of 2024 Net income of $51.5 million compared to $30.5 million in the third quarter of 2024 Adjusted net income(1) increased 70.0% to $55.2 million compared to $32.4 million in the third quarter of 2024 Total...

Continue reading

Globus Medical Reports Third Quarter 2025 Results

AUDUBON, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2025.Worldwide net sales were $769.0 million, an increase of 22.9%, or an increase of 22.3% on a constant currency basis Base business, excluding Nevro, net sales were $669.8 million, an increase of 7.0%, or an increase of 6.5% on a constant currency basis GAAP net income for the quarter was $119.0 million GAAP diluted earnings per share (“EPS”) was $0.88 and non-GAAP diluted EPS was $1.18, increasing 134.0% and 42.6%, respectively“We are pleased with the strength of our overall results and continued progress throughout the company,” commented Keith Pfeil, President and Chief Executive Officer. “Q3 revenue rose 23%, driven by...

Continue reading

Microchip Technology Announces Financial Results for Second Quarter of Fiscal Year 2026

Net sales of $1.140 billion, increased 6.0% sequentially and declined 2.0% from the year ago quarter. The midpoint of our guidance provided on August 7, 2025 was net sales of $1.130 billion. On a GAAP basis: gross profit of 55.9%; operating income of $88.9 million and 7.8% of net sales; net income attributable to common stockholders of $13.9 million; and EPS of $0.03 per diluted share. Our guidance provided on August 7, 2025 was for GAAP EPS loss per diluted share of $0.04 to $0.01. On a Non-GAAP basis: gross profit of 56.7%; operating income of $277.2 million and 24.3% of net sales; net income of $199.1 million; and EPS of $0.35 per diluted share. Our guidance provided on August 7, 2025 was for Non-GAAP EPS per diluted share of $0.30 to $0.36. Returned approximately $245.8 million to common stockholders in the September quarter through...

Continue reading

HCI Group Reports Third Quarter 2025 Results

TAMPA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI), reported pre-tax income of $90.6 million and net income of $67.9 million for the third quarter of 2025 compared with pre-tax income of $14.1 million and net income of $9.4 million for the third quarter of 2024. Net income after noncontrolling interests was $65.5 million compared with $5.7 million in the third quarter of 2024. Diluted earnings per share were $4.90 in the third quarter of 2025, compared with $0.52 in the third quarter of 2024. Management Commentary“This was another strong quarter, marked by solid profitability, industry-leading net combined ratios, and meaningful growth in book value per share,” said HCI Group Chairman and Chief Executive Officer Paresh Patel. “Most importantly, we progressed our initiative to unlock shareholder value and establish...

Continue reading

Alta Equipment Group Announces Third Quarter 2025 Financial Results

Third Quarter Financial Highlights:Total revenues decreased $26.2 million year over year to $422.6 million Material Handling revenues decreased $1.0 million year over year to $167.9 million, while Construction Equipment and Master Distribution revenues decreased a combined $23.9 million year over year to $256.6 million Product support revenues increased 1.1% year over year to $141.7 million for the quarter Product support gross profit percentage increased 160 basis points year over year to 47.2% Selling, general and administrative expenses decreased by $4.7 million year over year Income tax expense of $24.4 million primarily related to valuation allowance impacts of the One Big Beautiful Bill Act (“OBBBA”) Net loss available to common stockholders of $(42.3) million Basic and diluted net loss per share of $(1.31) Adjusted basic and...

Continue reading

AMN Healthcare Announces Third Quarter 2025 Results

Quarterly revenue of $634 million and adjusted EBITDA of $58 million; GAAP income of $0.76/share and adjusted EPS of $0.39 DALLAS, Nov. 06, 2025 (GLOBE NEWSWIRE) — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2025 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts.  Q3 2025 % Change Q3 2024 YTD September 30, 2025 % Change YTD September 30, 2024Revenue $634.5 (8%) $1,982.2 (12%)Gross profit $184.4 (13%) $578.9 (17%)Net income (loss) $29.3 319% $(88.0) nmDiluted income (loss) per share $0.76 322% $(2.29) nmAdjusted diluted EPS* $0.39 (36%) $1.14 (55%)Adjusted EBITDA* $57.5 (22%) $180.0 (32%)* See “Non-GAAP Measures” below...

Continue reading

Certara Reports Third Quarter 2025 Financial Results

Updates Full Year 2025 Financial Guidance RADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal year 2025. Third Quarter Highlights:Revenue was $104.6 million, compared to $94.8 million in the third quarter of 2024, representing growth of 10%.Software revenue was $43.8 million, compared to $35.9 million in the third quarter of 2024, representing growth of 22%. Services revenue was $60.8 million, compared to $58.9 million in the third quarter of 2024, representing growth of 3%.Net income was $1.5 million, compared to a net loss of $1.4 million in the third quarter of 2024, representing growth of 211%. Adjusted EBITDA was $35.2 million, compared to $33.1 million in the third quarter...

Continue reading

Euronext publishes Q3 2025 results and announces a share repurchase programme

Euronext publishes Q3 2025 results and announces a share repurchase programme Euronext has delivered the sixth consecutive quarter of double-digit growth, driven by the expansion of non-volume-related businesses, resilient trading and clearing revenues and continued cost discipline. Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 6 November 2025 – Euronext, the leading European capital market infrastructure, today publishes its results for the third quarter of 2025.Q3 2025 revenue and income was up +10.6%1 to €438.1 million:Non-volume-related revenue and income represented 60% of total revenue and income and covered 162% of underlying operating expenses, excluding D&A2:Securities Services revenues grew to €77.3 million (+6.0%), driven by double-digit revenue growth in custody and settlement, supported by sustainable...

Continue reading

Akwel: Nine-month revenue down -3.6%

        Champfromier — Thursday, November 6, 2025 NINE-MONTH REVENUE DOWN -3.6% AKWEL (FR0000053027, AKW, PEA-eligible), parts and systems manufacturer for the automotive and heavy-vehicle industry, specialist in fluid management, mechanisms and structural parts for electric vehicles, has recorded, over the first 9 months of 2025, a published consolidated revenue of €730.7M. Consolidated revenue (from January 1 to September 30, 2025)in €m — unaudited 2025 2024 Variation PCC variation (1)1st quarter 255.6 263.5 -3.0% -4.0%2nd quarter 255.0 265.3 -3.9% -2.7%3rd quarter 220.1 228.9 -3.9% -2.0%Nine-month total 730.7 757.7 -3.6% -3.0%(1)   At constant scope and exchange rates. In the third quarter of the year, AKWEL recorded a decline in reported activity of -3.9%, which is comparable to previous quarters, and -2.0% at constant...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.